Sixteen Swiss hospitals take part in coronavirus global Solidarity trial
University Hospital Lausanne is coordinating the trial in Switzerland.
Keystone / Laurent Gillieron
Some 1,000 patients in Switzerland are expected to participate in trials of experimental treatments for Covid-19 as part of the WHO global Solidarity trial.
Launched in March under the auspices of the World Health Organisation, the Solidarity trialExternal link aims to generate reliable data on the effectiveness and side effects of potential treatments.
While randomized clinical trials normally take years to design and conduct, the Solidarity trial is expected to reduce the time by 80% by enrolling patients in one single randomized trial. This will overcome the risk of multiple small trials not generating strong enough evidence.
The WHO has selected four therapies for testing based on laboratory, animal and clinical studies evidence of their potential to treat Covid-19. This includes remdesivir, chloroquine or hydroxychloroquine, lopinavir plus ritonavir, and interferon-beta. Novartis recently announced it was donating up to 130 million doses of the antimalarial drug hydroxychloroquine in part to advance clinical trials.
Switzerland is one of some 70 countries participating in the effort along with France, Spain, South Africa and Canada. The Swiss National Science Foundation (SNSF) has provided CHF1.6 million to the global trial and is working closely with the Federal Office of Public Health. Lausanne University Hospital CHUV is coordinating Switzerland’s participation in the tiral.
The sixteen hospital centres are the university hospitals of Lausanne, Geneva, Bern and Basel, the hospital networks of Valais and Neuchâtel, along with several cantonal hospitals. The hospitals are expected to recruit up to 1,000 patients to take part in the study according to a statementExternal link from CHUV.
The trial in Switzerland is expected to last from three months to one year but will depend in part on the evolution of the epidemic. The study may include up to 1,000 adult hospitalized patients who have not yet received treatment with Covid-19.
According to the WHOExternal link, patients diagnosed with COVID-19 and who have consented to be part of the study will be randomly selected to receive either local standard care alone or local standard care and one of a list of study drugs.
SNSF also announced that it has received 284 grant applicationsExternal link for its special call for coronavirus research issued in March. Funding decisions are expected to be communicated around mid-May 2020.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
This content was published on
The ceasefire in the Iran-Israel war has visibly eased tensions on the financial markets. The SMI, Switzerland's leading stock market index, has risen above the 12,000 point mark again.
This content was published on
Geneva, which is facing several days of very hot weather, has raised its level of vigilance with regard to the risk of forest fires and is issuing an appeal for caution.
Zurich arbitration authority rules in favour of tenants of ‘Sugus Houses’
This content was published on
A conciliation authority says the terminations of 105 flat leases in the so-called "Sugus Houses" in the centre of Zurich were abusive. The tenants therefore do not have to move out - at least for the time being.
This content was published on
Visitors to Switzerland spent CHF19.6 billion ($23.9 billion) last year, a 2.2% rise compared to the previous year, the Federal Statistical Office (FSO) said on Monday.
This content was published on
Despite the current tense economic situation, Swiss consumer sentiment remains positive. The Swiss spent more money in May than the previous year, particularly on restaurant visits and leisure activities, as shown by the latest figures released by PostFinance.
This content was published on
A bear killed four sheep in the Lower Engadine region near Scuol, canton Graubünden, last week. This was the first bear attack on local livestock in four years.
This content was published on
Experts believe that economic development in Switzerland will be weaker in 2026 than the forecasts made three months ago. They have also lowered their predictions for the current year.
This content was published on
Fewer people in Switzerland have a religious affiliation and the proportion who practice their religion regularly is steadily declining, a survey finds.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
WHO and Roche launch trials of potential coronavirus treatments
This content was published on
Roche is launching a clinical trial of a potential new Covid-19 drug, adding to rapidly growing investments in combating coronavirus.
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies' balancing act between hope and scientific realities.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.